Nasal Swab Test Can Improve Early Lung Cancer Assessment
Data supports that a noninvasive nasal swab test can help physicians more accurately assess lung cancer risk in patients with lung nodules.
Read MorePosted by Chris Wolski | Oct 21, 2021 | Lung Cancer |
Data supports that a noninvasive nasal swab test can help physicians more accurately assess lung cancer risk in patients with lung nodules.
Read MorePosted by Chris Wolski | Oct 19, 2021 | Breast |
Quest Diagnostics will provide clinical laboratory testing using the Ki-67 IHC MIB-1 pharmDx (Dako Omnis) immunohistochemistry companion diagnostic.
Read MorePosted by Chris Wolski | Oct 13, 2021 | Miscellaneous, Molecular Diagnostics |
California’s SB 535 prohibits insurers that already cover biomarker testing from requiring prior authorization for patients with advanced stage cancer.
Read MorePosted by Toni Mitchell | Oct 5, 2021 | Prostate, Uncategorized |
New research from a team of scientists — and two specially trained dogs — have scientifically validated man’s best friend can “sniff out” prostate cancer.
Read MorePosted by Toni Mitchell | Oct 1, 2021 | Breast, Lung Cancer, Molecular Diagnostics |
OneOncology and Genentech presented data at a symposium that examined genomic profiling and biomarker testing patterns in community oncology centers.
Read More